Glutaraldehyde-modified recombinant Fel d 1: A hypoallergen with negligible biological activity but retained immunogenicity

World Allergy Organization Journal

Volumn 4, Issue 7, 2011, Pages 113-120

  Versteeg, Serge A ^a   Bulder, Ingrid ^b   Himly, Martin ^c   Van Capel, Toni M ^a   Van Den Hout, R ^d   Koppelman, Stef J ^d   De Jong, Esther C ^a   Ferreira, Fatima ^c   Van Ree, Ronald ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

^c UNIVERSITY OF SALZBURG   (Austria)

^d R and D Department   (Netherlands)

Author keywords

Allergoid; Feld 1; Felis domesticus; Hypoallergen; Immunotherapy

Indexed keywords

CAP BINDING PROTEIN; FEL D 1; GLUTARALDEHYDE; IMMUNOGLOBULIN E; RECOMBINANT ALLERGEN; UNCLASSIFIED DRUG;

ALLERGENICITY; ANIMAL EXPERIMENT; ARTICLE; BASOPHIL; BINDING AFFINITY; BIOASSAY; CELL PROLIFERATION; CHEMICAL MODIFICATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNOGENICITY; IMMUNOREACTIVITY; NONHUMAN; PHYSICAL CHEMISTRY; PICHIA PASTORIS; PRIORITY JOURNAL; PROTEIN BINDING; RADIOALLERGOSORBENT TEST; RADIOIMMUNOASSAY; T LYMPHOCYTE;

EID: 80052748973     PISSN: 19394551     EISSN: None     Source Type: Journal    
DOI: 10.1097/WOX.0b013e3182228a39     Document Type: Article

References (37)

1. van Ree R, van Leeuwen WA, Bulder I, Bond J, Aalberse RC. Purified natural and recombinant Fel d 1 and cat albumin in in vitro diagnostics for cat allergy. J Allergy Clin Immunol. 1999;104:1223-1230. (Pubitemid 30004984)
2. Kleine-Tebbe J, Kleine-Tebbe A, Jeep S, Schou C, Lowenstein H, Kunkel G. Role of the major allergen (Fel d I) in patients sensitized to cat allergens. Int Arch Allergy Immunol. 1993;100:256-262. (Pubitemid 23104765)
3. Ohman JL Jr, Lowell FC, Bloch KJ. Allergens of mammalian origin. III. Properties of a major feline allergen. J Immunol. 1974;113:1668-1677.
4. Lowenstein H, Lind P, Weeke B. Identification and clinical significance of allergenic molecules of cat origin. Part of the DAS 76 Study. Allergy. 1985;40:430-441. (Pubitemid 16256631)
5. Duffort O, Carreira J, Lombardero M. Monoclonal antibodies against Fel d I and other clinically relevant cat allergens. Immunol Lett. 1988;17: 71-77. (Pubitemid 18049381)
6. de Groot H, van Swieten P, van Leeuwen J, Lind P, Aalberse RC. Monoclonal antibodies to the major feline allergen Fel d I. I. Serologic and biologic activity of affinity-purified Fel d I and of Fel d I-depleted extract. J Allergy Clin Immunol. 1988;82:778-786. (Pubitemid 19003097)
7. Ewbank PA, Murray J, Sanders K, Curran-Everett D, Dreskin S, Nelson HS. A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract. J Allergy Clin Immunol. 2003;111: 155-161. (Pubitemid 36143307)
8. Varney VA, Edwards J, Tabbah K, Brewster H, Mavroleon G, Frew AJ. Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial. Clin Exp Allergy. 1997;27:860-867. (Pubitemid 27359850)
9. Kristensen AK, Schou C, Roepstorff P. Determination of isoforms, N-linked glycan structure and disulfide bond linkages of the major cat allergen Fel d1 by a mass spectrometric approach. Biol Chem. 1997; 378:899-908. (Pubitemid 27388952)
10. Morgenstern JP, Griffith IJ, Brauer AW, Rogers BL, Bond JF, Chapman MD, Kuo MC. Amino acid sequence of Fel dI, the major allergen of the domestic cat: protein sequence analysis and cDNA cloning. Proc Natl AcadSciUSA. 1991;88:9690-9694. (Pubitemid 21915697)
11. Griffith IJ, Craig S, Pollock J, Yu XB, Morgenstern JP, Rogers BL. Expression and genomic structure of the genes encoding FdI, the major allergen from the domestic cat. Gene. 1992;113:263-268.
12. Kaiser L, Gronlund H, Sandalova T, Ljunggren HG, van Hage-Hamsten M, Achour A, Schneider G. The crystal structure of the major cat allergen Fel d 1, a member of the secretoglobin family. J Biol Chem. 2003;278:37730-37735. (Pubitemid 37175298)
13. Rogers BL, Morgenstern JP, Garman RD, Bond JF, Kuo MC. Recom-binant Fel d.I: Expression, purification, IgE binding and reaction with cat-allergic human T cells. Mol Immunol. 1993;30:559-568.
14. Slunt JB, Rogers BL, Chapman MD. IgE antibodies to recombinant forms of Fel d I: dichotomy between fluid-phase and solid-phase binding studies. J Allergy Clin Immunol. 1995;95:1221-1228.
15. Keating KM, Segal DB, Craig SJ, Nault AK, Semensi V, et al. Enhanced immunoreactivity and preferential heterodimer formation of reassociated Fel d I recombinant chains. Mol Immunol. 1995;32:287-293.
16. Ichikawa K, Wen W, Wu Z, Vailes LD, Guyre P, Chapman MD. Fully immunoreactive recombinant cat allergen, Fel d 1, expressed in bacu-lovirus [abstract]. J Allergy Clin Immunol. 1999;103:S184.
17. Vailes LD, Sun AW, Ichikawa K, Wu Z, Sulahian TH, Chapman MD, Guyre PM. High-level expression of immunoreactive recombinant cat allergen (fel d 1): Targeting to antigen-presenting cells. J Allergy Clin Immunol. 2002;110:757-762. (Pubitemid 35423179)
18. Kaiser L, Gronlund H, Sandalova T, Ljunggren HG, Schneider G, van Hage-Hamsten M, Achour A. Production, crystallization and preliminary crystallographic study of the major cat allergen Fel d 1. Acta Crystallogr D Biol Crystallogr. 2003;59:1103-1105. (Pubitemid 36689416)
19. Ferreira F, Ebner C, Kramer B, Casari G, Briza P, et al. Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoal-lergenic variants for immunotherapy. FASEB J. 1998;12:231-242. (Pubitemid 28080193)
20. Markovic-Housley Z, Degano M, Lamba D, von Roepenack-Lahaye E, Clemens S, et al. Crystal structure of a hypoallergenic isoform of the major birch pollen allergen Bet v 1 and its likely biological function as a plant steroid carrier. J Mol Biol. 2003;325:123-133. (Pubitemid 36153002)
21. Rabjohn P, West CM, Connaughton C, Sampson HA, Helm RM, Burks AW, Bannon GA Modification of peanut allergen Ara h 3: effects on IgE binding and T cell stimulation. Int Arch AllergyImmunol. 2002;128:15-23. (Pubitemid 34621662)
22. Bannon GA, Cockrell G, Connaughton C, West CM, Helm R, et al. Engineering, characterization and in vitro efficacy of the major peanut allergens for use in immunotherapy. Int Arch Allergy Immunol. 2001; 124:70-72. (Pubitemid 32304765)
23. Akdis CA, Blaser K. Regulation of specific immune responses by chemical and structural modifications of allergens. Int Arch Allergy Immunol. 2000;121:261-269. (Pubitemid 30229638)
24. Norman PS, Lichtenstein LM, Marsh DG. Studies on allergoids from naturally occurring allergens. IV. Efficacy and safety of long-term allergoid treatment of ragweed hay fever. J Allergy Clin Immunol. 1981;68:460-470. (Pubitemid 12254024)
25. Norman PS, Lichtenstein LM, Kagey-Sobotka A, Marsh DG. Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever. J Allergy Clin Immunol. 1982;70:248-260. (Pubitemid 12036065)
26. De Jonge J, Brissinck J, Heirman C, Demanet C, Leo O, Moser M, Thielemans K. Production and characterization of bispecific single-chain antibody fragments. Mol Immunol. 1995;32:1405-1412. (Pubitemid 26064906)
27. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985; 150:76-85. (Pubitemid 16258399)
28. van Milligen FJ, van Swieten P, Aalberse RC. Structure of the major cat allergen FeldIindifferent allergen sources: an immunoblotting analysis with monoclonal antibodies against denatured Fel d I and human IgE. Int Arch Allergy Immunol. 1992;99:63-73. (Pubitemid 23010355)
29. Bolhaar ST, Ree R, Bruijnzeel-Koomen CA, Knulst AC, Zuidmeer L. Allergy to jackfruit: a novel example of Bet v 1-related food allergy. Allergy. 2004;59:1187-1192. (Pubitemid 39389473)
30. Carnes J, Himly M, Gallego M, Iraola V, Robinson DS, Fenmndez-Caldas E, Briza P. Detection of allergen composition and in vivo immunogenicity of depigmented allergoids of Betula alba. Clin Exp Allergy. 2009;39:426-434.
31. Aalberse RC, Koshte V, Clemens JG. Immunoglobulin E antibodies that crossreact with vegetable foods, pollen, and Hymenoptera venom. J Allergy Clin Immunol. 1981;68:356-364. (Pubitemid 12235138)
32. van Ree R, van Leeuwen WA, van den BM, Weller HH, Aalberse RC. IgE and IgG cross-reactivity among Lol p I and Lol p II/III. Identification of the C-termini of Lol p I, II, and III as cross-reactive structures. Allergy. 1994;49:254-261. (Pubitemid 24131451)
33. Chapman MD, Aalberse RC, Brown MJ, Platts-Mills TA. Monoclonal antibodies to the major feline allergen Fel d I. II. Single step affinity purification of Fel d I, N-terminal sequence analysis, and development of a sensitive two-site immunoassay to assess Fel d I exposure. J Immunol. 1988;140:812-818. (Pubitemid 18067267)
34. Kleine Budde I, de Heer PG, van der Zee JS, Aalberse RC. The stripped basophil histamine release bioassay as a tool for the detection of allergen-specific IgE in serum. Int Arch Allergy Immunol. 2001;126: 277-285. (Pubitemid 34124193)
35. Knol EF, Kuijpers TW, Mul FP, Roos D. Stimulation of human baso-phils results in homotypic aggregation. A response independent of degranulation. J Immunol. 1993;151:4926-4933. (Pubitemid 23318546)
36. Siraganian RP. Refinements in the automated fluorometric histamine analysis system. J Immunol Methods. 1975;7:283-290.
37. Akdis CA, Akdis M. Mechanisms and treatment ofallergic disease in the big picture ofregulatory T cells. JAllergyClin Immunol. 2009;123:735-746.